197 related articles for article (PubMed ID: 16460541)
1. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores.
Kim SH; Park WB; Lee CS; Kang CI; Bang JW; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Microbiol Infect; 2006 Jan; 12(1):13-21. PubMed ID: 16460541
[TBL] [Abstract][Full Text] [Related]
2. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Kim SH; Park WB; Lee KD; Kang CI; Bang JW; Kim HB; Kim EC; Oh MD; Choe KW
J Antimicrob Chemother; 2004 Aug; 54(2):489-97. PubMed ID: 15254028
[TBL] [Abstract][Full Text] [Related]
3. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
Kim SH; Kim KH; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2008 Jan; 52(1):192-7. PubMed ID: 17984229
[TBL] [Abstract][Full Text] [Related]
4. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
Paul M; Kariv G; Goldberg E; Raskin M; Shaked H; Hazzan R; Samra Z; Paghis D; Bishara J; Leibovici L
J Antimicrob Chemother; 2010 Dec; 65(12):2658-65. PubMed ID: 20947620
[TBL] [Abstract][Full Text] [Related]
5. Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis.
Yoon YK; Park DW; Sohn JW; Kim HY; Kim YS; Lee CS; Lee MS; Ryu SY; Jang HC; Choi YJ; Kang CI; Choi HJ; Lee SS; Kim SW; Kim SI; Kim ES; Kim JY; Yang KS; Peck KR; Kim MJ
BMC Infect Dis; 2016 Jul; 16():331. PubMed ID: 27418274
[TBL] [Abstract][Full Text] [Related]
6. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
[TBL] [Abstract][Full Text] [Related]
7. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
[TBL] [Abstract][Full Text] [Related]
8. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
Nissen JL; Skov R; Knudsen JD; Ostergaard C; Schønheyder HC; Frimodt-Møller N; Benfield T
J Antimicrob Chemother; 2013 Aug; 68(8):1894-900. PubMed ID: 23599360
[TBL] [Abstract][Full Text] [Related]
10. Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Bigseth RS; Sandholdt H; Petersen A; Østergaard C; Benfield T; Thorlacius-Ussing L
Microbiol Spectr; 2022 Jun; 10(3):e0153021. PubMed ID: 35438533
[TBL] [Abstract][Full Text] [Related]
11. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
[TBL] [Abstract][Full Text] [Related]
13. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
[TBL] [Abstract][Full Text] [Related]
14. Adherence to standards of care and mortality in the management of Staphylococcus aureus bacteraemia in Peru: A prospective cohort study.
Schwalb A; Cachay R; de la Flor A; García C; Seas C
Int J Infect Dis; 2020 Jul; 96():601-606. PubMed ID: 32505877
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
[TBL] [Abstract][Full Text] [Related]
16. Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study.
López-Cortés LE; Gálvez-Acebal J; Del Toro MD; Velasco C; de Cueto M; Caballero FJ; Muniain MA; Pascual A; Rodríguez-Baño J
PLoS One; 2013; 8(12):e82958. PubMed ID: 24376617
[TBL] [Abstract][Full Text] [Related]
17. Differential impacts of inappropriate empirical therapy on ED patients with Staphylococcus aureus and streptococci bacteremia.
Lee CH; Yang CY; Hsieh CC; Hong MY; Lee CC
Am J Emerg Med; 2020 May; 38(5):940-946. PubMed ID: 31493980
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
[TBL] [Abstract][Full Text] [Related]
19. Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.
Smith JR; Frens JJ; Snider CB; Claeys KC
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):50-54. PubMed ID: 29153470
[TBL] [Abstract][Full Text] [Related]
20. Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates.
Yahav D; Shaked H; Goldberg E; Yassin S; Eliakim-Raz N; Paul M; Bishara J; Leibovici L
Infection; 2017 Feb; 45(1):51-57. PubMed ID: 27411532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
